Publikasjoner
- Clinical outcomes of genomically guided trametinib monotherapy across cancer types: results from the IMPRESS-Norway trial
- A classifier for patient-derived colorectal tumoroid drug sensitivity using confocal imaging and growth rate inhibition metrics
- Path-based quantification of activation and repression in Boolean models using BooLEVARD Les publikasjonen
- Constraint based modeling of drug induced metabolic changes in a cancer cell line
- Continuous imaging to evaluate growth and drug responses of patient-derived colorectal tumouroids Les publikasjonen
- Exploring doctors’ perspectives on precision medicine and AI in colorectal cancer: opportunities and challenges for the doctor-patient relationship Les publikasjonen
- High-content morphological profiling by Cell Painting in 3D spheroids
- Dynamic Boolean modeling of molecular and cellular interactions in psoriasis predicts drug target candidates Les publikasjonen
- Immune digital twins for complex human pathologies: applications, limitations, and challenges Les publikasjonen
- Synergistic effects of complex drug combinations in colorectal cancer cells predicted by logical modelling
Annen formidling
- Har uhelbredelig kreft – lever lenger med skreddersydd cellegift
- Continuous Imaging to Evaluate Growth and Drug Responses of Patient-Derived Colorectal Tumouroids
- Miniaturization of patient- and stem cell derived organoids – increasing throughput and reproducibility
- Panel: Challenges and Opportunities for Precision Medicine
- 456 Molecular characteristics of gynaecological cancer patients in the IMPRESS-Norway trial – a national prospective, non-randomized clinical trial evaluating the efficacy of anti-cancer drugs on new indications
- Functional assays for personalized medicine
- Author Correction: High-throughput screening reveals higher synergistic effect of MEK inhibitor combinations in colon cancer spheroids (Scientific Reports, (2020), 10, 1, (11574), 10.1038/s41598-020-68441-0)